Piperacillin/tazobactam versus imipenem: a double-blind, randomized formulary feasibility study at a major teaching hospital

Authors
Category Primary study
Year 1998
This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. P/T is a suitable alternative to imipenem as it has a similar efficacy and tolerance profile and, additionally, the costs of both treatment courses are similar.
Epistemonikos ID: e305575cb13318fb6dc67fcab7dc69beff3286ba
First added on: Apr 19, 2023